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The ability to optically manipulate specific neuronal signaling proteins with genetic
precision paves the way for the dissection of their roles in brain function, behavior,
and disease. Chemical optogenetic control with photoswitchable tethered ligands
(PTLs) enables rapid, reversible and reproducible activation or block of specific
neurotransmitter-gated receptors and ion channels in specific cells. In this study, we
further engineered and characterized the light-activated GluK2 kainate receptor, LiGluR,
to develop a toolbox of LiGluR variants. Low-affinity LiGluRs allow for efficient optical
control of GluK2 while removing activation by native glutamate, whereas variant RNA
edited versions enable the synaptic role of receptors with high and low Ca2+ permeability
to be assessed and spectral variant photoswitches provide flexibility in illumination.
Importantly, we establish that LiGluR works efficiently in the cortex of awake, adult mice
using standard optogenetic techniques, thus opening the door to probing the role of
specific synaptic receptors and cellular signals in the neural circuit operations of the
mammalian brain in normal conditions and in disease. The principals developed in this
study are widely relevant to the engineering and in vivo use of optically controllable
proteins, including other neurotransmitter receptors.
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INTRODUCTION
The ability to manipulate neuronal activity using optogenetic tools is a powerful technique for
probing synaptic transmission and plasticity, mapping neural circuits, and exploring the cellular
basis of behaviors in a variety of organisms (Fenno et al., 2011; Miesenböck, 2011). Most studies
rely on expression of non-native light-sensitive proteins, such as opsins, which can either elicit or
inhibit action potential firing in genetically defined cells. This method is suitable for probing circuit
function and associated behavioral correlates but is limited in its ability to provide insight into the
subcellular, molecular events that underlie brain function. Signaling in neurons occurs through
numerous mechanisms, which involve a wide variety of proteins including diverse families of ion
channels, transporters, G protein-coupled receptors, and enzymes. To probe the molecular basis
of the various physiological functions of the nervous system one requires a method to manipulate
natively expressed signaling proteins with the spatial, temporal, and genetic precision afforded by
optogenetics.
Levitz et al. In vivo Optical Manipulation of Glutamate Receptors
Glutamate serves as the major excitatory neurotransmitter in
the central nervous system and exerts its effects primarily via
glutamate receptors (GluRs), including both ionotropic (iGluRs)
and metabotropic (mGluRs) receptors (Niswender and Conn,
2010; Traynelis et al., 2010). The molecular diversity of GluRs
and their overlapping expression patterns make it difficult to
fully dissect how individual receptor subtypes contribute to
neuronal signaling, behavior, and neurological disorders using
classical pharmacological or genetic techniques. For instance,
many of the same receptor subtypes are expressed in multiple
compartments within the same synapse or multiple cell types
within the same brain region. Furthermore, RNA editing,
post-translational modifications, accessory subunits and the
formation of heteromers further complicate the interpretation of
such experiments. Finally, the temporal profile of native GluR
activation is difficult to replicate with the coarse control afforded
by soluble pharmacological agents or genetic manipulations.
For these reasons optochemical approaches, such as caged
compounds, have been developed to enhance both the spatial
and temporal manipulation of GluRs (Callaway and Yuste, 2002;
Ellis-Davies, 2007). While valuable approaches both in vitro
and in vivo, these techniques are limited spatiotemporally by
diffusion, limited in pharmacological specificity, and cannot
allow one to exert genetic control to target specific cells
or to introduce mutations that alter receptor function in a
defined way.
We have previously employed a chemical optogenetic
approach to optically control individual GluRs based on
photoswitchable tethered ligands (PTLs) (Reiner et al., 2015).
PTLs are modular photoswitches that site-specifically attach
covalently to a protein of interest and reversibly present a
functional group via photoisomerization of a light-sensitive
moiety, such as azobenzene (Kramer et al., 2013). Even
compared to other optical techniques, PTLs allow particularly
precise spatiotemporal control since the photoisomerization
of azobenzene is a picosecond process and binding is not
limited by diffusion. The covalent attachment of the PTL to the
target protein provides complete subtype specificity compared to
soluble pharmacological agents. Genetic targeting of proteins can
allow further precision by pinpointing photocontrol to specific
sites within a neural circuit. PTLs of the MAG (Maleimide-
Azobenzene-Glutamate) family have been successfully used to
engineer light-gated iGluRs, termed LiGluRs (Volgraf et al.,
2006; Gorostiza et al., 2007) and mGluRs, termed LimGluRs
(Levitz et al., 2013). LiGluR is based on the kainate receptor
GluK2 (formerly GluR6), which plays distinct roles at excitatory
and inhibitory synapses throughout the brain and has been
implicated in a variety of neurological diseases, including mood
disorders and epilepsy (Contractor et al., 2011; Lerma and
Marques, 2013). This tool has been used to optically manipulate
GluK2 activity and, thus, control cellular excitability in cultured
neurons and glia (Szobota et al., 2007; Hou et al., 2011; Li et al.,
2012), brain slice (Janovjak et al., 2010), and in vivo in zebrafish
(Szobota et al., 2007; Wyart et al., 2009), fruit fly (Kauwe and
Isacoff, 2013), and mouse retina (Caporale et al., 2011; Gaub
et al., 2014). PTL-based optical control of GluRs remains to be
demonstrated in the mouse brain in vivo where it would be
a particularly powerful tool for deciphering the roles of GluR
signaling in physiology and disease.
The further use of LiGluRs raises a number of challenges
related to the engineering and application of such tools. PTL-
based approaches provide a high degree of modularity, since
receptor and ligand can be changed in a rational and largely
independent way that allows one to alter the tool in order to
optimize it for the application of interest. By further engineering
LiGluRs we can gain more insight into how these tools function
pharmacologically and biophysically while gaining a further level
of control over receptor function. In addition, a key remaining
step for the application of LiGluRs would be the ability to
establish optical control in vivo in the brain of rodents. This
work fully establishes a family of variants of LiGluR with tuneable
glutamate affinity, spectral properties, and ion selectivity that
functions to control neuronal firing. We also find that LiGluR
can be used to manipulate neuronal firing using either dual-
color or single-color photoswitches in vivo in the cortex of the
adult mouse. Ultimately, this work will lead to a finely-tuned
molecular optogenetic approach to study the role of specific
proteins ranging from the cellular to network to organismal level.
MATERIALS AND METHODS
Preparation of Photoswitches
Chemical synthesis of L-MAG0, L-MAG1, and L-MAG0460 was
performed as described previously (Volgraf et al., 2006; Kienzler
et al., 2013). Photoswitches were dissolved in dry DMSO (stock
concentration∼50mM) and stored at−20◦C.
Electrophysiological Characterization of
LiGluRs in HEK Cells and Cultured
Hippocampal Neurons
LiGluR [rat GluK2(L439C) a isoform] variants were generated by
site-directed mutagenesis and used as either untagged versions
in a pcDNA3 vector, or tagged with enhanced green fluorescent
protein (EGFP) in a pNICE vector. The amino acid numbering
includes the wild-type signal peptide. C-terminally EGFP-tagged
constructs were used to test for LiGluR localization in cultured
neurons and in some current clamp recordings, but did not
show any differences in function or expression level compared
to untagged constructs.
Whole-cell recordings were performed at room temperature
(22–24◦C) using an Axopatch 200B headstage/amplifier
(Molecular Devices) on an inverted microscope (Olympus IX
series). Voltage-clamp recordings were typically performed
at −75mV. Data were analyzed with Clampfit (Molecular
Devices) and ProFit (Quantumsoft).
A Xe-lamp light source was used for photoswitching, either a
DG4 (Sutter) in combination with excitation filters (379/34 nm
and 500/24 nm for regular MAG, 445/20 nm for MAG460,
“center”/full width >90%) or a Polychrome V monochromator
(Till Photonics; 15 nm FWHM bandwidth). A liquid light guide
was used for coupling of the light source to the back-port of
the inverted microscope and homogeneous epi-illumination was
achieved through a 40x LUCPlanFLN NA 0.60 FN 22 objective
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(Olympus). Neutral density filters (Omegafilters) were used to
vary the light intensity, which was measured at the sample stage
using a power meter (Thorlabs).
HEK cell recordings were performed as described previously
(Reiner and Isacoff, 2014a). Cells were transfected using
Lipofectamine 2000 (Invitrogen). A plasmid encoding yellow
fluorescent protein (YFP) was co-transfected to yield a
fluorescent marker protein. After 24-48 h expression at 37◦C,
the cells were washed with external solution (see below) and
briefly incubated with 0.3mg/ml concanavalin A (ConA) to
suppress ligand-induced desensitization. Labeling was performed
for 40min at room temperature using∼50µMMAG in external
solution and the cells were thoroughly washed with external
solution to remove any unreacted MAG. The extracellular
solution contained (in mM): 138 NaCl, 1.5 KCl, 1.2 MgCl2, 2.5
CaCl2, 10 glucose, 10 HEPES, pH 7.3. Patch pipettes were pulled
from borosilicate glass to give 3-7M resistance, when filled with
internal solution containing (in mM): 135 K-gluconate, 10 NaCl,
10 HEPES, 2 MgCl2, 2 MgATP, 1 EGTA, pH 7.4.
The apparent glutamate affinity (EC50) of different GluK2
variants (Figure 3A) was determined by obtaining dose
response-curves in whole-cell recordings from HEK cells in the
presence of ConA. A Hill-type equation:







was fitted to data from individual cells and subsequently used to
calculate the relative current amplitudes. The average of this data
is reported in Figure 3A, along with a fit of Equation (1) to this
average. For GluK2 (E738D), which was not fully saturated with
30mM glutamate, we slightly modified this procedure. Here we
first averaged the titration data obtained from four independent
cells by normalizing the currents relative to the current obtained
with 10mM glutamate. This average is reported in Figure 3A
and subsequent fitting of Equation (1) yielded the corresponding
parameters. Normalizing the data to 3 or 30mM glutamate
yielded similar results.
Dissociated hippocampal neuron cultures were prepared from
postnatal P0 or P1 mice on 12mm glass coverslips as previously
described (Levitz et al., 2013). Neurons were transfected with
GluK2 (L439C) or GluK2 (L439C, K487A) (1.5µg/well) and
tdTomato (0.25µg/well as a transfection marker) using the
calcium phosphate method at DIV9. Whole cell patch clamp
experiments were performed 3–6 days after transfection (DIV
12-15). Labeling was performed for 40min at room temperature
using ∼50µM MAG in labeling solution containing (in mM):
150 NMDG, 2.5 KCl, 0.5 CaCl2, 5 MgCl2, 5 glucose, 10 HEPES,
pH 7.5. Recordings were performed in extracellular solution
containing (in mM): 138 NaCl, 1.5 KCl, 1.2 MgCl2, 2.5 CaCl2,
10 glucose, 5 HEPES, pH 7.4. Glass pipettes of resistance 5–
10 M were filled with an intracellular solution containing (in
mM): 140 K-gluconate, 10 NaCl, 5 EGTA, 2 MgCl2, 1 CaCl2, 10
HEPES, 2 MgATP, and 0.3 Na2GTP, pH 7.2. Current was injected
to compare the optical depolarization from a standard potential
of−60mV (Figure 3F). Confocal imaging of GFP-tagged LiGluR
constructs was performed on a Zeiss LSM780 AxioExaminer.
Virus Production and Expression
AAV production was carried out using standard methods
(Grieger et al., 2006). Either AAV2 or AAV7M8 (Dalkara
et al., 2013) capsids were used to package LiGluR and GFP
viruses. Mice were sacrificed ≤3 weeks after injection to assess
expression. For immunohistochemistry mice were perfused
with 4% paraformaldehyde and 100µM slices were prepared
and stained with a monoclonal anti-GluK2/GluK3 antibody
(Millipore) and imaged with a Zeiss LSM780 AxioExaminer
confocal microscope. Due to the poor labeling of native receptors
with the anti-GluK2/GluK3 antibody (not shown), we were only
able to observe heterologously over-expressed LiGluR above
background levels.
Surgical Procedures
For all surgical procedures, mice were anesthetized and
maintained with a 1.5% isoflurane and oxygen mixture. A
craniotomy was made above the target region (V1) using
stereotaxic coordinates relative to lambda (0.8mm anterior,
2.2mm lateral), and 0.5–1µl of viral particles (∼1013–1014 viral
genomes/ml) were deposited at a depth of 0.8mm below the
surface of the brain using a Nanoject system (Drummond).
Additionally, somemice were fitted with small screws attached to
the skull with dental acrylic (Teets, AM Systems), for subsequent
head-fixing in a custom made setup. The area was then covered
with a silicon sealant (Kwik-Cast, WPI).
For electrophysiological recordings mice underwent a second
surgical procedure (3–6 weeks later) during which 1µl of 100µM
L-MAG0 or L-MAG0460 was injected at the same V1 location. A
custom made movable optrode (similar to Anikeeva et al., 2012)
was positioned at the brain surface, and fixed with dental acrylic.
Mice were allowed to recover for at least 3 h prior to the recording
session.
in vivo Optical Manipulation and Electrical
Recording
The mouse was head-fixed with a custom made metal piece
(eMachineShop, NJ) able to accommodate the screws implanted
during surgery, and connected to a breadboard through post
holders (Thorlabs). The body of the mouse was placed in an
acrylic tube (McMaster-Carr), and the entire setup was housed
in a sound-attenuated box.
Optical stimulation was achieved with a custom dual laser
system consisting of a 375 nm diode laser (16mW, Coherent)
and a 532 nm DPSS laser (50mW, Laserglow Technologies). The
free laser beams were combined using a 405 nm dichroic mirror
(Semrock) and focused into a single optical fiber using a 10x
objective (NA 0.25, f = 16.5mm, Newport) mounted on a fiber
coupler (F91-C1-T, Newport). Single wavelength stimulation was
performed with a fiber-coupled 472 nm laser (Shanghai Laser &
Optics Century Co.). In all cases, light was delivered through a
200µmmultimode fiber (NA 0.39, Thorlabs) coupled to ceramic
ferrules (Precision Fiber Products Inc.). The intensity of the
laser was adjusted based on neuronal responses, and typically
resulted in a total power at the end of the fiber of 1–4mW. Laser
illumination was controlled by a computer with a PCI-DAQ
board (National Instruments) and custom software developed in
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Matlab (Mathworks, software freely available at https://github.
com/andpopes/LaserStim.git). Neuronal activity was recorded
with a movable optrode, consisting of a 200µm optic fiber
surrounded by up to 16 single wire electrodes (California Fine
Wire). The construct was similar to Anikeeva et al. (2012),
and allowed precise sampling of electrical activity and optical
stimulation across various depths. Signals were amplified with
a 32-channel TDT RZ5 unit (Tucker-Davis Technologies),
digitized at 25 kHz and stored on a computer.
Prior to recordings, each mouse was gradually habituated
to head-fixing (5–45min) over a period of 5 days. On the
experimental day mice underwent a second surgical procedure
for L-MAG injection (see above), at the end of which the optrode
construct was positioned just below the cortical surface. The
neuronal responses to various laser stimulation patterns were
sampled at depths spanning the entire cortical layer (∼1mm), in
100µm steps over a period of ∼1 h. Only one recording session
was performed for each mouse. In some cases, optrodes were
advanced only halfway, and the procedure resumed 24 h later.
Single units were identified off-line using principal
component analysis with custom software written in Matlab.
To identify units significantly modulated by the activation of
LiGluRs we measured the firing rates during the first second of
laser stimulation, and calculated the fold-change from baseline
(1 s prior to laser):
Fold change = (FR during UV− FR during baseline)/
FR during baseline,
where FR is the firing rate. A unit was considered responsive if
the fold change was consistently higher (or lower) than 99.9% of
values similarly computed with shuﬄed spikes (10,000 repeats).
Animal Research
All mouse experiments were performed with approval of the
University of California Animal Care and Use Committee. The
wt mice (C57BL/6J) were purchased from the Jackson Laboratory
and the age of the mice ranged from p50–p80 for rAAV injections
and from p80–p120 for in vivo experiments.
RESULTS
Tuning the LiGluR Response with MAG
Photoswitch Variants
Direct optical control of glutamate receptors is achieved by
covalently attaching a PTL to the receptor of interest. LiGluR
is a light-gated ionotropic glutamate receptor that is based
on the kainate receptor GluK2, which is expressed with a
cysteine substitution (L439C) close to the ligand binding site
and conjugated with a PTL of the L-MAG family (Figure 1A;
Figure S1) (Volgraf et al., 2006; Gorostiza et al., 2007). Once
the MAG ligands are attached to the receptor via a maleimide-
cysteine linkage, they can activate GluK2 in response to
light, which isomerizes the MAG azobenzene moiety from
trans to cis, reversibly presenting the glutamate headgroup
to the ligand binding domain (Figure 1A). Deactivation is
achieved by isomerizing the MAG ligand back to its trans
configuration, retracting the ligand from its binding site.
The glutamate headgroup of L-MAGs resembles (2S,4R)-4-
methylglutamate (SYM 2081), a high-efficacy agonist with some
selectivity for kainate receptors (Zhou et al., 1997; Traynelis
et al., 2010). The relative efficacy of the ligand in the two
photoswitch conformations can be modulated by varying the
MAG linker length (L-MAG0, 1 and 2; Figure S1; Numano et al.,
2009).
The response of LiGluR to light is largely determined by the
photophysical properties of the MAG photoswitch. Chemical
substitutions to the azobenzene core allow tuning of the spectral
sensitivity and of the on/off characteristics of LiGluR in a
rational manner (Gorostiza et al., 2007; Kienzler et al., 2013;
Izquierdo-Serra et al., 2014; Rullo et al., 2014) (Figure 1). For
in vivo applications, two aspects are particularly important: First,
regular MAGs offer bistability: light of 370–405 nm leads to
receptor activation with sustained activation in the dark, but a
second wavelength of light, >480 nm, is needed to turn LiGluR
off (Figure 1B), since the spontaneous cis-to-trans relaxation
of regular MAGs is slow (tens of minutes; Gorostiza et al.,
2007). Because of this, we predict a second property, which is
useful for in vivo applications and which we demonstrate here.
We had previously shown that high light intensities can be
used to control LiGluR with submillisecond time resolution to
mimic the relevant synaptic timescales and produces the fast and
pronounced desensitization typical for kainate receptors (Reiner
and Isacoff, 2014b).We now show that maximal photo-activation
is independent of light intensity (Figure 1B, gray line). Lowering
the light intensity slowed activation and deactivation, but resulted
in the same current amplitude, as expected for a system with a
very slow spontaneous back-rate (Figure 1B, gray line).
In contrast, LiGluR-MAG460 (GluK2 (L439C)+ L-MAG0460)
is activated with visible light (maximal activation with blue,
460 nm light) and spontaneously relaxes back to the trans
configuration within less than a second in the dark (Kienzler
et al., 2013) (Figure 1C). We find lower light intensities to both
slow activation and result in a smaller amplitude photo-current
(Figure 1C, gray line), as predicted for a systemwith a substantial
spontaneous back-rate (Gaub et al., 2014). Thus, intensity can be
used to tune the amplitude of LiGluR-MAG0460 photo-current.
LiGluR expresses well in cultured neurons where it traffics
throughout fine processes (Figure 2A). Since GluK2 is a
nonspecific cation channel that natively contributes to the
generation of excitatory postsynaptic currents (Lerma, 2003)
LiGluR depolarizes neurons in a light-dependent manner
(Szobota et al., 2007). Current-clamp recordings of cultured
hippocampal neurons expressing LiGluR revealed robust
depolarization in a bistable and fully reversible fashion,
which is sufficient to induce reproducible bouts of action
potential firing (Figure 2B). Importantly, we found that
LiGluR-MAG0460 induces comparable depolarizations at
blue light intensities typical for optogenetic experiments
(∼1mW/mm2). As expected for LiGluR-MAG0460, turning
off the light leads to spontaneous deactivation and a return
to the baseline potential (Figure 2C). Pulses of 445 nm light
(∼1mW/mm2) were sufficient to induce large inward currents
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FIGURE 1 | Operating principles of light-gated glutamate receptors (LiGluRs). (A) LiGluRs are optogenetic tools that can be expressed in genetically targeted
cells (blue). They are based on an engineered iGluR subunit, which is expressed in the desired cell type and conjugated with a synthetic photoswitchable ligand, called
MAG. Photoisomerization of the covalently bound MAG ligand from trans to cis presents the glutamate moiety to the glutamate binding site, which leads to ligand
binding and ion channel opening. (B) Photoswitching of LiGluR labeled with a regular, bistable MAG ligand (Volgraf et al., 2006; Gorostiza et al., 2007). Illumination
with 380 nm light (violet bar) leads to an inward current as shown in a voltage-clamp recording of a LiGluR-expressing HEK cell labeled with L-MAG0. The receptor
activation is sustained in the dark and turned off by illumination with 500 nm light (green bar). (Left) Switching is fully reversible as demonstrated with two consecutive
switching cycles. (Right) Lowering the light intensity leads to slower photo-activation and deactivation kinetics, but the same current amplitude (black
trace ∼7-8mW/mm2; gray trace ∼0.7-0.8mW/mm2; see also Figure S2). (C) Photoswitching of LiGluR labeled with L-MAG0460,a blue light activated photoswitch
with a fast spontaneous cis-to-trans relaxation (Kienzler et al., 2013). (Left) HEK cell voltage-clamp recording showing two switching cycles with 445 nm light (blue
bar). Once the blue light is turned off, LiGluR turns off spontaneously. (Right) Lowering the light intensity results in slower activation kinetics and a decreased response
(black trace ∼1.5mW/mm2; gray trace ∼0.1mW/mm2 ). HEK cell recordings were performed in the presence of ConA.
in voltage-clamp mode (Figure 2D) and brief (3ms) pulses of
light were found to be sufficient to elicit single action potentials
(Figure 2E). This demonstrates that L-MAG0460 provides
a powerful addition to optical control for kainate receptors
in vivo, which provides the advantage of requiring only light
of a single, blue wavelength, thereby leaving the rest of the
visible spectrum for other optical manipulation or detection
tools.
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FIGURE 2 | Light-induced depolarization and optical control of neuronal firing with LiGluR. (A) LiGluR-GFP expression in a cultured hippocampal neuron
visualized with confocal imaging. Scale bar = 20µm. (B) LiGluR labeling with conventional L-MAG0 allows for optical depolarization in a bistable fashion: 375 nm light
(violet bar) depolarizes the cells, which results in an increase in action potential firing, illumination with 480 nm light (green bar) readily reverses the effect (current-clamp
recording at Vrest = −60mV). (C–E) LiGluR labeled with L-MAG0460 allows optical control of neuronal firing with light of a single, blue wavelength. (C) The effect of
445 nm illumination (blue bar) reverses spontaneously in the dark (current-clamp recording at Vrest = −57mV). (D) Voltage-clamp recording at −60mV showing
inward currents resulting from long (seconds) and short (5ms) 445 nm light pulses. (E) Short 445 nm light pulses (arrows; 3ms) are sufficient to elicit single action
potentials (current-clamp recording at Ubase = −47mV).
Tuning the Physiological Function of
LiGluR by Receptor Engineering
Apart from its optical controllability, LiGluR resembles
native GluK2 receptors in all key aspects, displaying normal
glutamate affinity (Gorostiza et al., 2007) as well as normal
desensitization and recovery properties (Reiner and Isacoff,
2014b). Moreover, pharmacological antagonists, such as DNQX,
are still able to block the response to glutamate or MAG
photoswitching (Gorostiza et al., 2007). It should also be noted
that photoactivation can be performed on the synaptic (i.e.,
submillisecond) timescale and that photo-activation results
in the fast and pronounced desensitization typical for kainate
receptors (Reiner and Isacoff, 2014b). The conservation of native
GluK2 properties provides an opportunity to further engineer
LiGluR based on known principles of receptor function in order
to make designer variants for specific applications.
When LiGluR is introduced in neurons it will, presumably,
contribute to neuronal signal transmission like any other GluK2
subunit and will respond to endogenous glutamate released
from presynaptic neurons. This is favorable in some scenarios,
particularly after a knock-in of the L439C mutation into the
native receptor gene, but may be less desirable in other cases, in
which LiGluR is expressed ectopically. A fully orthogonal LiGluR,
meaning a receptor that is only activated by light but not by
glutamate, would also be useful to probe the role of this receptor
against the background of normal glutamatergic transmission.
We therefore attempted to place additional mutations in LiGluR
to lower its affinity for glutamate, while maintaining robust
expression and high enough affinity to respond to MAG. We
hypothesized that this is plausible since MAG, as a covalently
attached ligand, is present at a high effective concentrations
(>10mM) when isomerized to the cis configuration (Gorostiza
et al., 2007).
Two mutations turned out to be particularly useful for
lowering the glutamate affinity of LiGluR. The first of these
was at K487, an amino acid that is located on the tip of the
ligand binding cleft, which stabilizes the closed conformation
of the ligand binding domain that is thought to cause receptor
activation. As previously reported (Weston et al., 2006), the
mutation of this residue to alanine (K487A) reduced the
sensitivity of LiGluR to glutamate ∼20-fold, resulting in an
apparent EC50 of (0.70 ± 0.16) mM in the presence of
concanavalin A (ConA) (Figure 3A). LiGluR (K487A), which we
named “low-affinity LiGluR” (LA-LiGluR), could be labeled and
optically controlled with L-MAG0, yielding robust photocurrents
(Figure 3B, top). LA-LiGluR could also be photo-controlled
with L-MAG0460 (Figure 3B, bottom). This suggests that despite
subtle differences in chemical structure (Figure S1), this MAG
variant is also able to present the glutamate headgroup at a
high effective concentration in the cis state. The spontaneous
relaxation properties of L-MAG0460 were not affected by the
reduced affinity of LA-LiGluR (Figure S3), suggesting that
deactivation is rate-limited by thermal relaxation in the dark of
L-MAG0460 back to the more stable trans state, rather than by
the binding energy of the glutamate in the binding pocket.
We found that LA-LiGluR expresses well in neurons, traffics
into distant dendritic branches as well as spines, and that it can
be used to efficiently control neuronal firing (Figures 3C–F).
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FIGURE 3 | Engineering and characterization of LiGluR variants with low glutamate affinity. (A) Glutamate dose-response properties of LiGluR, LA-LiGluR
[LiGluR(K487A)] and ULA-LiGluR [LiGluR(E738D)] obtained from HEK cell voltage-clamp recordings in the presence of Con A. Apparent affinities were determined by
fitting with a Hill-type equation, which yielded EC50 = (0.70 ± 0.16) mM (Θ = 1.00± 0.07, n = 3 cells) for LA-LiGluR, and EC50 = (10.0 ± 2.6) mM (Θ = 0.95 ± 0.10,
n = 4 cells) for ULA-LiGluR. Data points report the mean ± s.d.. LiGluR was reported to have a glutamate EC50 = (52 ± 1) µM (from Gorostiza et al., 2007). (B)
Photoactivation of LA-LiGluR after labeling with regular L-MAG0 (top) and L-MAG0460 (bottom). Voltage-clamp recordings in the presence of ConA with DG4
illumination (1–2mW/mm2 ), (C) Confocal image of hippocampal neurons expressing LA-LiGluR-EGFP. Scale bars = 10µm. (D) Optical control of hippocampal
neurons using LA-LiGluR-EGFP labeled with regular L-MAG0 (current-clamp recording at Vrest = −76mV), or, (E) labeled with L-MAG0460 (current-clamp recording
at Vbase = −40mV). (F) Summary of light-induced depolarization achieved with different combinations of LiGluR and MAG from a common potential of −60mV
(mean ± s.d. with number of cells). An ANOVA test did not detect significant differences between the groups (n.s.).
A direct comparison of LiGluR and LA-LiGluR combined
with either L-MAG0 or L-MAG0460 revealed no significant
differences in the capacity to depolarize hippocampal neurons
(Figure 3F). Due to its low affinity, LA-LiGluR should not
respond to endogenous baseline levels of glutamate, although
it may respond weakly to synaptic glutamate. We therefore
next sought to decrease the glutamate affinity of LiGluR even
further to make a fully orthogonal receptor that is controlled
by light only and no longer responds to physiological levels of
glutamate.
To further lower the affinity of LiGluR we turned to the
glutamate to aspartate mutation at residue 738 (E738D), which
has been shown to result in an extremely low glutamate affinity
(Mah et al., 2005). This amino acid is directly positioned in
the glutamate binding pocket. The apparent EC50 of LiGluR
(E738D) was estimated to be 10.0 ± 2.6mM in the presence
of ConA, that is ∼200-fold lower than wild type, leading us to
name LiGluR (E738D) ultra-low affinity LiGluR (“ULA-LiGluR”)
(Figure 3A). This affinity is so low that ULA-LiGluR is not
expected to respond even during peak glutamate in the synaptic
cleft following transmitter release. Despite its ultra-low affinity,
ULA-LiGluR expressed well and could be photo-controlled with
L-MAG1 (Figure S4A). Interestingly, the slightly shorter L-
MAG0 was unable to optically manipulate this variant (data
not shown). Together, these experiments show that the local
concentration of MAG is high enough to overcome decreases in
apparent glutamate affinity of up to 200-fold, while maintaining
fast photo-activation and deactivation.
An important and distinguishing characteristic of iGluRs is
their variable selectivity for monovalent vs. divalent cations,
which results in different Ca2+ permeabilities. GluK2 can
undergo RNA editing at a key pore-lining residue that
controls its permeability to Ca2+ (Egebjerg and Heinemann,
1993; Dingledine et al., 1999). LiGluR is based on the
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unedited GluK2(Q) form (Q621), which shows substantial Ca2+
conductance (Burnashev et al., 1995). LiGluR photo-activation
hence leads to a significant influx of Ca2+ (Volgraf et al.,
2006; Izquierdo-Serra et al., 2013; Carroll et al., 2015), which
acts as a 2nd messenger that can trigger intracellular signaling
events and changes in synaptic plasticity. We sought to make
a version of LiGluR [“LiGluR(R)”] based on the edited form
(Q621R) to reduce Ca2+ influx (Burnashev et al., 1995). We
found that LiGluR(R) maintains robust L-MAG0 photoswitching
(Figure S4B). This now provides us with the ability to optically
control both the high and low Ca2+ permeability versions of
GluK2 receptors for the analysis of their roles at synapses, as
well as to produce membrane depolarization with high and
low Ca2+ influx. Ultimately, comparison of both the edited
and un-edited versions of LiGluR can allow one to probe
the role of Ca2+ vs. monovalent ion influx in physiological
functions.
In summary, these results highlight the modularity of LiGluR,
where changes can be made to the photoswitch to tune the
photo-response and to the receptor to change its physiological
action.
Optical Control of LiGluR in Mouse Cortex
in vivo
Having established a family of LiGluR variants with a range of
properties, we next turned to the intact mammalian brain. While
fundamental work on glutamate receptor neurobiology may be
done in simplified in vitro or ex vivo systems, as well as in model
organisms, rodents offer the ability to control specific proteins
within the intact circuits of a mammalian brain. Controlling
specific GluRs in vivo in mice using PTLs opens the door to
probing specific GluR function in physiological, behavioral and
pathological contexts with previously unattainable precision.
The ability to control neuronal activity with LiGluR in vivo
was tested with common techniques, by combining viral delivery
of LiGluR with local fiber-mediated optical stimulation and
extracellular recordings (Anikeeva et al., 2012). We expressed
LiGluR in the V1 area of the visual cortex of adult mice (8–
10 weeks old) using an adeno-associated virus (AAV) under
the control of the hsyn promoter to broadly target neurons
(Figure 4A, top). GluK2 is natively expressed throughout the
neocortex where it modulates cell and network excitability
through a variety of mechanisms (Petralia et al., 1994; Contractor
et al., 2011; Lerma and Marques, 2013). Three to 6 weeks
following AAV injection provided sufficient time for detection of
added GluK2 expression around the injection site (Figure 4A).
Following this period, L-MAG0 was injected and an optrode was
implanted at the same injection site. After >3 h of post-surgical
recovery, mice were connected through an optical fiber to a
dual laser illumination system (Figure 4B), and neuronal activity
was monitored. As expected for optical activation of GluK2
in neocortex, brief illumination with 375 nm light produced a
rapid increase in neuronal firing that was stable in the dark,
and reversed by 532 nm illumination (Figure 4C). Repeated
photoactivation and deactivation cycles produced a highly
repeatable modulation of firing in individual cells (Figure 4E).
In contrast, control mice injected with a GFP virus, followed
by the same delayed L-MAG0 injection and optrode placement
did not show any light response (Figures 4D,F). Measurement
of local field potential (LFP) confirmed the increase in neuronal
activity induced by LiGluR activation (Figure 4G), but not
in MAG-injected, GFP-infected mice (Figure 4H). LiGluR-
induced optical manipulation of firing rates occurred with post-
illumination delays as short as ∼30ms with averages in the 70–
150ms range as expected for the light intensity used in this
experiment (Figures 5A,B). The repeatability and rapid kinetics
of LiGluR photoactivation allowed entrainment of neuronal
firing at frequencies up to 5Hz (Figures 5C,D). Figure 5E shows
a summary of all recorded cells in both LiGluR and GFP mice.
In LiGluR injected mice (n = 4), activation with 375 nm
light induced a significant increase in the firing rate of 60%
of recorded neurons (with 7% showing a >10-fold increase),
and a significant decrease in 4% of neurons (see methods). In
contrast, similar light stimuli did not elicit this effect in GFP-
injected mice (n = 3; 0% of neurons showed an increase,
2% showed a decrease in firing rates). Chi-squared analysis
revealed a significant difference between the distribution of non-
responsive, up and down- regulated firing rates for the two
groups (Chi2 = 11.53, df = 2, p = 0.003). Baseline firing
rates of recorded neurons varied greatly in both groups (values
between 0.7 and 23Hz), consistent with a pan-neuronal viral
transfection. Furthermore, we did not observe any significant
difference between baseline firing rates in the experimental
vs. control groups indicating that MAG labeling and LiGluR
expression did not alter the basal firing rates of the region
(Figure 5F).
We next tested L-MAG0460 in vivo to establish single
wavelength optical control of LiGluR in mouse cortex. Following
infection with AAV-LiGluR and injection of L-MAG0460 in
V1 (n = 2), 473 nm illumination produced a rapid and
repeatable increase in neuronal firing that was reversible in
the dark (Figures 6A,B) on a similar time scale to cultured
cell experiments (Figure 1C). Similar to L-MAG0, L-MAG0460
activation led to a strong LFP response in V1 (Figure 6C).
L-MAG0460-mediated photoactivation of LiGluR resulted in
manipulation of firing rates on similar time scales to L-MAG0
(Figure 6D). Consistent with the pan-neuronal expression of
the hsyn promoter, we observed occasional inhibitory light
responses, presumably from feed-forward inhibition (Figure
S5). Unlike L-MAG0, which populates a wavelength-dependent
photostationary state that is light intensity-independent, titration
of laser intensity led to a tuneable response in V1 neurons
labeled with L-MAG0460 (Figures 6E,F). Finally, we wondered
if a single injection of MAG molecules could allow for optical
control of LiGluR over a longer time period than hours following
injection. 24 h after injection of L-MAG0460 in V1 we still
observed robust photoactivation of LiGluR-expressing neurons
(Figures 6G,H), indicating that MAG labeling and LiGluR
surface expression is stable for at least a day following injection.
This is consistent with recent work in the retina showing LiGluR-
mediated light responses for up to 2 weeks following injection
(Gaub et al., 2014) and indicates that LiGluR may be used
in vivo for behavioral assays that last for days rather than
hours.
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DISCUSSION
In this study, we establish for the first time that LiGluR may
be used in vivo in the neocortex of adult mice in conjunction
with fiber-based optogenetic technologies to allow for rapid
optical control of GluK2 activity. AAV-mediated expression of
LiGluR in visual cortex was found to produce sufficient levels of
surface GluK2 in cortical neurons after ∼3 weeks. MAG labeling
FIGURE 4 | In vivo optical control of LiGluR in the visual cortex of awake mice. (A) Top, map for AAV vector used to produce AAV-hsyn-LiGluR. Bottom,
expression of GluK2/LiGluR in V1 neurons as visualized by immunohistochemistry. Scale bars = 200µm, left and 10µm, right. (B) Schematic showing experimental
setup of in vivo electrophysiology experiments. A TTL-controlled dual laser system was connected to an optrode which was implanted into V1 of an awake,
head-fixed mouse and was attached to a TDT-Rz5 amplifier. (C,D) Representative recordings from either a LiGluR (C) or GFP (D) injected mouse following L-MAG0
injection. Top, unfiltered recordings of electrical activity in response to 375 nm (violet) or 532 nm (green) illumination. Bottom, high-pass filtered electrical recordings.
(E,F), Representative raster plots for individual units showing repeatability of LiGluR photoactivation (E) and no response in neurons not infected with LiGluR (F). (G)
Local field potential (LFP) responses to LiGluR activation were observed for L-MAG0. Data is presented as normalized power (z-axis, color coded) as a function of time
(x-axis) and frequency (y-axis). Power was normalized to the 1 s period prior to laser stimulation for each frequency. (H) No LFP response was observed in
GFP-injected mice.
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FIGURE 5 | Further characterization of in vivo optical control of LiGluR. (A) Summary of light response from a representative cell showing the speed of
response. (B) Kinetics for the activation (purple) and inactivation (green) of LiGluR with L-MAG0. Values represent the delay between the onset of laser stimulation and
the earliest change in firing rate, averaged across all single units recorded. Data is presented as mean ± s.e.m. (C) Representative filtered recording from V1 of a
LiGluR-expressing and L-MAG0-labeled mouse showing high frequency light responses. (D) Summary of firing rate changes in a representative cell in response to
high frequency photoswitching. (E) Summary histogram for all units recorded from either LiGluR (black) or GFP (gray) -infected mice. (F) Baseline firing rates (y-axis,
mean ± s.e.m.) for periods between laser stimulations, in mice expressing LiGluR or GFP. No difference was observed between the two groups.
occurs rapidly following injection, shows no gross adverse effects
on animal or tissue health, permits selective photoactivation
of engineered receptors within a pool of native receptors, and
remains bound to LiGluR for at least 24 h post-labeling. This
tremendously expands the applicability ofMAGphotoswitches to
control LiGluRs (and likely LimGluRs), which have already found
successful application in brain slices, flies and zebrafsh larvae, as
well as the retina of mice and dogs (Reiner et al., 2015). Our work
complements previous studies in cell culture that have shown
that LiGluR expression and labeling does not alter cell health
(Szobota et al., 2007) or the number of presynaptic inputs (Hou
et al., 2011), and that MAG photoswitches likely do not activate
receptors at the labeling concentrations used (Volgraf et al.,
2006). Consistent with these previous controls, in vivo firing rates
were similar in cortical regions expressing LiGluR or GFP. In the
future, it will be important to complete a characterization of the
synaptic effects of LiGluR expression, labeling, and activation.
Here we focused on the neocortex because of its importance
as an integrating circuit in the nervous system and since it is
a context where glutamate transmission is prominent. LiGluR
photoactivation could induce more than a 10-fold increase in
firing rate with rapid onset and offset (as fast as ∼30ms; average
∼100ms). Photoswitching was highly reversible and repeatable
over many trials. Importantly, mice injected with GFP viruses
followed by MAG injection showed no light response. LiGluR-
mediated photoswitching was seen throughout all layers of the
cortex, indicating that this approach will likely work throughout
all regions of the mammalian brain where optical fibers can
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 February 2016 | Volume 9 | Article 2
Levitz et al. In vivo Optical Manipulation of Glutamate Receptors
FIGURE 6 | Single wavelength optical control of LiGluR in vivo with L-MAG0460. (A,B) LiGluR activation with L-MAG0460 results in increased firing in response
to 473 nm light that is rapid, repeatable and spontaneously-reversed in the dark. (C) LFP changes are observed in response to LiGluR activation with L-MAG0460. (D)
Kinetics for the activation (blue) and inactivation (gray) of LiGluR using L-MAG0460. (E) Representative recording showing power-dependence of LiGluR
photoactivation with L-MAG0460. (F) Summary of power-dependence of photoactivation for a representative cell. (G,H) 24 h post MAG injection light responses to
473 nm light were maintained.
be implanted. The success of LiGluR in vivo will pave the
way for further application of PTL-based tools in order to
probe specific proteins in circuit function and higher-level brain
activity. Baseline firing rates varied greatly between neurons
regardless of the experimental protocol, representative of the
many cortical neuronal types. As illustrated above, LiGluR-
mediated photoactivation modulated the activity of both low-
firing (Figure 4) and fast-firing neurons (Figure 6). Combined
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with the ability to manipulate a high percentage (60%) of cells
within a given cortical region, these data indicate that LiGluR-
mediated photoactivation is likely robust enough for behavioral
manipulations, as well as cell type-specific interrogation of
neuronal circuits.
We find that both dual-color “regular” MAG photoswitches
and single-color MAG460 photoswitches may be employed in
cultured neurons and in vivo with comparable efficacy. These
two families of photoswitches provide distinct advantages that
allow for the appropriate adaptation to the given application.
Regular MAGs offer bistability, which is optimal for high
time resolution or long time scale experiments. Furthermore,
owing to their stable photostationary states, regular MAGs are
highly light sensitive and largely intensity-independent. The
high sensitivity of regular MAGs also compensates any trade-
offs due to the poor tissue penetration of 380 nm light. On the
other hand, L-MAG0460 photoswitches offer the simplicity of
one color photocontrol, which is more easily compatible with
many illumination systems and may allow for easier complexing
with other optical tools. The intensity-dependence of L-MAG0460
allows for photoswitching effects to be titrated by adjusting
the laser intensity. In addition, MAG460 photoswitches, unlike
regular MAGs, may also be activated via two-photon infrared-
light illumination, which provides high spatial precision and
enhanced tissue penetration (Izquierdo-Serra et al., 2014; Carroll
et al., 2015). Recent experiments have also established activation
of LiGluR with red-light using tetra-ortho-chloro-substituted
MAGs (Rullo et al., 2014). Ultimately, the ability to manipulate
LiGluR photoactivation with either regular L-MAGs or L-
MAG0460 while modulating a variety of parameters (wavelength,
light intensity, etc.) allows one to mimic the properties of
pharmacological compounds with enhanced subtype specificity
while taking advantage of the enhanced spatial, temporal, and
genetic control of optogenetics.
A key feature of the PTL-based approach is that genetic
changes may be made to the protein of interest while maintaining
the ability to specifically manipulate it through photoswitch
conjugation. For example, one may make mutations to various
functional or regulatory sites within LiGluR without disrupting
its ability to become photo-activated by MAG, thus enabling
direct testing of the role of the mutated residues in receptor
function. This represents a major improvement in terms of
temporal and spatial control over classical knock-in approaches.
In this study we engineered a new LiGluR variant with decreased
Ca2+ permeability [“LiGluR(R)”] by mutating a single key
pore residue. Photoswitching of LiGluR(R) in neurons will
allow one to test the important of Ca2+ influx, as opposed to
membrane depolarization alone, in mediating the downstream,
physiological effects of GluK2. Similar mutational approaches
may be applied to make LiGluR variants with altered activation
and desensitization kinetics, phosphorylation sites, or other
properties based on the vast literature on kainate receptors.
In a similar vein we also used point mutations to engineer
LiGluR variants to respond only to light without the potentially
confounding effects of glutamate. LA-LiGluR and ULA-LiGluR
show photoswitching comparable to LiGluR despite a decrease
in apparent glutamate affinity of ∼10- or 200-fold, respectively.
Despite its lower glutamate affinity, GluK2 (K478A) was shown
to desensitize as completely as wild-type and to have only
slightly faster kinetics of deactivation, desensitization, and
recovery (Weston et al., 2006). This result indicates that the
glutamate moiety of MAG is in a high local concentration,
as previously proposed, allowing it to maintain efficacy in
the mutated variants. These low affinity LiGluR variants are
an important addition to the toolset for use in physiological
systems in which overexpression of glutamate receptors and
endogenous glutamate release may affect synaptic strength, since
they allow LiGluR photoactivation to remain orthogonal to native
signaling. These newly-developed LiGluR variants complement
other engineered LiGluR variants, such as GluK2 (G486C), which
is activated by the trans-isomer of MAG rather than the cis
isomer (Numano et al., 2009) and to the potassium selective
LiGluR “HyLighter,” which can be used to hyperpolarize neurons
(Janovjak et al., 2010). Together, these variants constitute a
LiGluR toolset that may be further enhanced by combination of
GluK2 mutants with different versions of L-MAG (Table 1).
Opsin-based optogenetic tools, like channelrhodopsin and
light-driven ion pumps, are widely used to control neuronal
function. In these cases, the expression of only a single, relatively
small construct allows for basic, yet robust control of neuronal
excitability by de- or hyper-polarization of selected cells, since
retinal is readily available in most model organisms. PTL-
based approaches, in contrast, are based on the application
of synthetic photoswitches to target genetically engineered
receptor constructs. While the labeling of receptors with a
PTL has to be optimized in each preparation and controls
on specificity have to be included, this approach offers a
number of distinct advantages. Importantly, the PTL-based
approach allows for the control of signaling proteins native
to the synapse. This allows one to manipulate more specific
functions compared to simply altering membrane potential. For
example, recent studies have used a photoswitchable mGluR2 to
control presynaptic inhibition in hippocampal neurons (Levitz
et al., 2013) and used a photoswitchable mGluR3 to manipulate
glutamate transport in astrocytes (Li et al., 2015). Thus, in
comparison to classical optogenetic approaches this PTL-based
strategy does not only allow one to control cellular excitability,
but to probe the function of specific receptor subtypes and
their contribution to behavior with unprecedented resolution.
This should help in overcoming limitations of transgenic and
pharmacological approaches currently used to study the function
of different glutamate receptor subtypes in different circuits. The
principles of this study will be widely applicable to other PTL-
based photoswitchable proteins such as metabotropic glutamate
receptors (Levitz et al., 2013), potassium channels (Banghart
et al., 2004, 2006; Fortin et al., 2011; Sandoz et al., 2012; Sandoz
and Levitz, 2013), P2X receptors (Lemoine et al., 2013; Browne
et al., 2014), GABAA receptors (Lin et al., 2014, 2015), and
nACh receptors (Tochitsky et al., 2012). In addition, the recent
development of a SNAP-based photoswitch labeling scheme that
is orthogonal to maleimide and can be used to control mGluRs
(Broichhagen et al., 2015), will further expand the ability to apply
these tools in experiments of increasing sophistication, including
those where multiple receptors are controlled within the same
Frontiers in Molecular Neuroscience | www.frontiersin.org 12 February 2016 | Volume 9 | Article 2
Levitz et al. In vivo Optical Manipulation of Glutamate Receptors
TABLE 1 | Summary of LiGluR variants.
A. MAG Photoswitch






Series of bistable photoswitches with
different linker lengths that turn LiGluRs on
and off with light of different wavelengths;
thermal relaxation occurs on slow
timescales (τ = 26min) rendering
switching bistable






activated) with fast thermal relaxation
(τmean = 0.71 s); also activated by white
light and 2-photons (850 nm)
Kienzler et al., 2013; Izquierdo-Serra et al.,
2014; Carroll et al., 2015
toCl-MAG1 cis: ∼ 380 nm,
>540 nm
trans: ∼ 440 nm
Activated with UV, yellow and red light (but
slower kinetics at comparable light
intensities); bistability through slow thermal
relaxation (τ = 5 h)
Rullo et al., 2014
B. Engineered Receptor
Name Mutations Key features References
LiGluR L439C General light activated glutamate receptor
based on GluK2(Q)*; cis-MAGs cause
receptor activation, which results in
depolarization
Volgraf et al., 2006; Gorostiza et al., 2007
LA-LiGluR L439C K487A Reduced sensitivity to glutamate (EC50∼





L439C E738D Strongly reduced sensitivity to glutamate
(EC50∼ 10mM) while L-MAG1
photoswitching is retained
This study





G486C Reversed mode of action (trans-activated
with L-MAG0)





Janovjak et al., 2010
Versatile LiGluR toolset provided by combining (A) different MAG photoswitches with (B) engineered receptors variants.
* standard LiGluR is based on the GluK2a isoform with Q621 (unedited).
preparation. Combination of these molecular approaches to
optical control with knock-in or CRISPR-mediated genetic
manipulation (Incontro et al., 2014; Platt et al., 2014), holds
great promise for a developing a powerful new way to
study the underlying molecular events that mediate brain
function.
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